- Home
- BBW vs PSNL Comparison
BBW vs PSNL Comparison
Compare BBW & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBW
- PSNL
- Stock Information
- Founded
- BBW 1997
- PSNL 2011
- Country
- BBW United States
- PSNL United States
- Employees
- BBW N/A
- PSNL N/A
- Industry
- BBW Recreational Games/Products/Toys
- PSNL Medical Specialities
- Sector
- BBW Consumer Discretionary
- PSNL Health Care
- Exchange
- BBW Nasdaq
- PSNL Nasdaq
- Market Cap
- BBW 526.4M
- PSNL 460.7M
- IPO Year
- BBW 2004
- PSNL 2019
- Fundamental
- Price
- BBW $39.45
- PSNL $3.45
- Analyst Decision
- BBW Strong Buy
- PSNL Strong Buy
- Analyst Count
- BBW 3
- PSNL 5
- Target Price
- BBW $54.33
- PSNL $7.80
- AVG Volume (30 Days)
- BBW 320.2K
- PSNL 883.3K
- Earning Date
- BBW 05-29-2025
- PSNL 05-07-2025
- Dividend Yield
- BBW 2.23%
- PSNL N/A
- EPS Growth
- BBW 4.11
- PSNL N/A
- EPS
- BBW 3.80
- PSNL N/A
- Revenue
- BBW $496,404,000.00
- PSNL $84,614,000.00
- Revenue This Year
- BBW $5.54
- PSNL N/A
- Revenue Next Year
- BBW $3.77
- PSNL $27.78
- P/E Ratio
- BBW $10.38
- PSNL N/A
- Revenue Growth
- BBW 2.12
- PSNL 15.15
- 52 Week Low
- BBW $23.63
- PSNL $1.14
- 52 Week High
- BBW $48.23
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- BBW 55.18
- PSNL 39.63
- Support Level
- BBW $35.28
- PSNL $3.33
- Resistance Level
- BBW $38.95
- PSNL $3.65
- Average True Range (ATR)
- BBW 2.04
- PSNL 0.25
- MACD
- BBW 0.25
- PSNL 0.03
- Stochastic Oscillator
- BBW 76.66
- PSNL 19.17
About BBW Build-A-Bear Workshop Inc.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.